These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7846982

  • 1. [Treatment of osteoporosis by the gynecologist].
    Schneider HP, Dören M.
    Zentralbl Gynakol; 1994; 116(12):691-4. PubMed ID: 7846982
    [Abstract] [Full Text] [Related]

  • 2. [Estrogen substitution in the postmenopause--effect and compliance].
    Dören M.
    Ther Umsch; 1994 Nov; 51(11):767-72. PubMed ID: 7839335
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estrogen-progestogen replacement therapy in postmenopausal women--is 1 mg estradiolvalerate sufficient to maintain axial trabecular bone density?
    Dören M, Schneider HP.
    Int J Clin Pharmacol Ther; 1994 May; 32(5):254-8. PubMed ID: 7921520
    [Abstract] [Full Text] [Related]

  • 5. [Treatment of osteoporosis with antiresorptive drugs].
    Vestergaard P, Mosekilde L, Brixen K.
    Ugeskr Laeger; 2005 Feb 21; 167(8):883-7. PubMed ID: 15789840
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of continuation of postmenopausal hormone replacement therapy: transdermal versus oral estrogen.
    Ettinger B, Pressman A, Bradley C.
    Menopause; 1998 Feb 21; 5(3):152-6. PubMed ID: 9774760
    [Abstract] [Full Text] [Related]

  • 9. Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.
    Morishige K, Yamamoto T, Sawada K, Ohmichi M, Tasaka K, Murata Y.
    Arch Gynecol Obstet; 2003 Jun 21; 268(2):105-6. PubMed ID: 12768299
    [Abstract] [Full Text] [Related]

  • 10. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A.
    Ann Acad Med Stetin; 2003 Jun 21; 49():111-30. PubMed ID: 15552843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Estrogens in prevention and treatment of osteoporosis.
    Lindsay R.
    Schweiz Med Wochenschr; 1989 Dec 16; 119(50):1806-10. PubMed ID: 2532784
    [Abstract] [Full Text] [Related]

  • 15. Influence of modified transdermal hormone replacement therapy on the concentrations of hormones, growth factors, and bone mineral density in women with osteopenia.
    Stanosz S, Zochowska E, Safranow K, Sieja K, Stanosz M.
    Metabolism; 2009 Jan 16; 58(1):1-7. PubMed ID: 19059524
    [Abstract] [Full Text] [Related]

  • 16. [Effect of hormone substitution therapy on AT III in women in the climacteric].
    Enzelsberger H, Heytmanek H, Kurz C, Metka M.
    Zentralbl Gynakol; 1991 Jan 16; 113(11):639-44. PubMed ID: 1656654
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Identification and treatment of postmenopausal women at risk for the development of osteoporosis.
    Dören M, Schneider HP.
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov 16; 30(11):431-3. PubMed ID: 1490769
    [Abstract] [Full Text] [Related]

  • 19. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA, Farias ML, Andrade AT.
    Climacteric; 2002 Sep 16; 5(3):286-92. PubMed ID: 12419087
    [Abstract] [Full Text] [Related]

  • 20. Estrogen therapy in postmenopausal osteoporosis. What we know and what we don't.
    Roux C.
    Rev Rhum Engl Ed; 1997 Jun 16; 64(6):402-9. PubMed ID: 9513613
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.